Q Therapeutics | Spinal Cord Injury Zone!

Q Therapeutics Approved to Start Trial of Cell Therapy Aiming to Restore Myelin

July 26, 2017

A cell therapy intended to boost myelin regeneration — Q-Cells by Q Therapeutics — has received a green light from the U.S. Food and Drug Administration to proceed with...

The mission of The Spinal Cord Injury Zone is to archive important Spinal Cord Injury News and Spinal Cord Injury Information for education and awareness. The Spinal Cord Injury Zone website is a not-for-profit Spinal Cord Injury educational Knowledge Base.

Tag: Q Therapeutics

Q Therapeutics Approved to Start Trial of Cell Therapy Aiming to Restore Myelin